Icu Medical Stock Fundamentals
| ICUI Stock | USD 174.81 3.20 1.80% |
ICU Medical fundamentals help investors to digest information that contributes to ICU Medical's financial success or failures. It also enables traders to predict the movement of ICU Stock. The fundamental analysis module provides a way to measure ICU Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICU Medical stock.
As of now, ICU Medical's Gross Profit is increasing as compared to previous years. The ICU Medical's current Other Operating Expenses is estimated to increase to about 2.3 B, while Operating Income is projected to decrease to under 31.1 M. ICU | Select Account or Indicator |
ICU Medical Company Profit Margin Analysis
ICU Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current ICU Medical Profit Margin | (0.03) % |
Most of ICU Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICU Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
ICU Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, ICU Medical has a Profit Margin of -0.0307%. This is 99.73% lower than that of the Health Care Equipment & Supplies sector and 99.83% lower than that of the Health Care industry. The profit margin for all United States stocks is 97.58% lower than that of the firm.
ICU Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ICU Medical's current stock value. Our valuation model uses many indicators to compare ICU Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICU Medical competition to find correlations between indicators driving ICU Medical's intrinsic value. More Info.ICU Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, ICU Medical's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ICU Medical's earnings, one of the primary drivers of an investment's value.ICU Medical's Earnings Breakdown by Geography
ICU Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICU Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics of similar companies.ICU Medical is currently under evaluation in profit margin category among its peers.
ICU Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICU Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICU Medical's managers, analysts, and investors.Environmental | Governance | Social |
ICU Fundamentals
| Return On Equity | -0.0341 | ||||
| Return On Asset | 0.0056 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 5.72 B | ||||
| Shares Outstanding | 24.43 M | ||||
| Shares Owned By Insiders | 7.85 % | ||||
| Shares Owned By Institutions | 96.01 % | ||||
| Number Of Shares Shorted | 652.49 K | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 2.14 X | ||||
| Price To Sales | 1.89 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 697.76 M | ||||
| EBITDA | 290.37 M | ||||
| Net Income | (29.66 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.7 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 83.43 X | ||||
| Cash Flow From Operations | 166.2 M | ||||
| Short Ratio | 2.30 X | ||||
| Earnings Per Share | (2.92) X | ||||
| Price To Earnings To Growth | 1.70 X | ||||
| Target Price | 176.4 | ||||
| Number Of Employees | 14 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 4.35 B | ||||
| Total Asset | 4.38 B | ||||
| Retained Earnings | 807.85 M | ||||
| Working Capital | 739.43 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
| Net Asset | 4.38 B |
About ICU Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 31.6 M | 33.2 M | |
| Total Revenue | 2.3 B | 2.4 B | |
| Cost Of Revenue | 1.5 B | 1.6 B | |
| Stock Based Compensation To Revenue | 0.02 | 0.01 | |
| Sales General And Administrative To Revenue | 0.25 | 0.28 | |
| Research And Ddevelopement To Revenue | 0.04 | 0.03 | |
| Capex To Revenue | 0.04 | 0.04 | |
| Revenue Per Share | 93.77 | 98.46 | |
| Ebit Per Revenue | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out ICU Medical Piotroski F Score and ICU Medical Altman Z Score analysis. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (2.92) | Revenue Per Share 95.155 | Quarterly Revenue Growth 0.086 | Return On Assets 0.0056 |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.